- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Mycetoma
Total 3397 results
-
Mayo ClinicRecruitingPlasma Cell MyelomaUnited States
-
K36 Therapeutics, Inc.RecruitingMultiple Myeloma | Myeloma | Myeloma MultipleUnited States, France, Spain, Canada
-
Emory UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLCRecruitingPlasma Cell MyelomaUnited States
-
AHS Cancer Control AlbertaTom Baker Cancer CentreRecruitingMyeloma | Myeloma MultipleCanada
-
Azienda Ospedaliera Universitaria SeneseJanssen-Cilag S.p.A.RecruitingMyeloma MultipleItaly
-
University Hospital, BordeauxRecruiting
-
Ivan S MoiseevTerminated
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingPlasma Cell MyelomaUnited States, Puerto Rico
-
SanofiTerminatedPlasma Cell MyelomaTaiwan, United States, Czechia, France, Greece, Spain
-
Emory UniversityNational Cancer Institute (NCI); Takeda; National Institutes of Health (NIH); Janssen...Active, not recruiting
-
Chong Kun Dang PharmaceuticalUnknownMyeloma, MultipleKorea, Republic of
-
Henan Cancer HospitalThe Pregene (ShenZhen) Biotechnology Company, Ltd.Unknown
-
Zhejiang UniversityYake Biotechnology Ltd.RecruitingRefractory Multiple Myeloma | Relapse Multiple MyelomaChina
-
Weill Medical College of Cornell UniversityJanssen Scientific Affairs, LLCRecruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapse Multiple MyelomaUnited States
-
Ionis Pharmaceuticals, Inc.Active, not recruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
TakedaCompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States, Canada
-
Gilead SciencesCompletedMultiple Myeloma | Myeloma, Plasma-Cell | PLASMACYTOMAUnited States
-
Sun Yat-sen UniversityChina Food and Drug AdministrationWithdrawnRelapse/Refractory Multiple MyelomaChina
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedRefractory Plasma Cell MyelomaUnited States
-
Ajai ChariAmgenCompletedRefractory Multiple Myeloma | Relapse Multiple MyelomaUnited States
-
Multiple Myeloma Research ConsortiumNot yet recruitingRefractory Multiple Myeloma | Relapse Multiple Myeloma
-
Massachusetts General HospitalPfizerRecruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapse Multiple MyelomaUnited States
-
Carl Ola Landgren, MD, PhDBristol-Myers SquibbRecruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Cristiana Costa Chase, DONot yet recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
PfizerRecruitingRefractory Multiple Myeloma | Relapse Multiple MyelomaItaly
-
Shenzhen University General HospitalRecruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapse Multiple MyelomaChina
-
Arbeitsgemeinschaft medikamentoese TumortherapieMedical University of Vienna; Sanofi; Assign Data Management and Biostatistics... and other collaboratorsRecruitingNewly Diagnosed Multiple MyelomaAustria, Greece, Serbia
-
Zhejiang UniversityYake Biotechnology Ltd.Not yet recruitingRefractory Multiple Myeloma | Relapse Multiple MyelomaChina
-
Multiple Myeloma Research ConsortiumEli Lilly and Company; GlaxoSmithKline; AbbVie; Takeda; Genentech, Inc.; Celgene Corporation and other collaboratorsRecruitingRelapsed Refractory Multiple MyelomaUnited States
-
AmgenCompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaCanada, Belgium, Spain, United States, Korea, Republic of, Australia, Czechia, Taiwan, Hungary, Austria, Romania, Japan, United Kingdom, Greece, Turkey, Bulgaria, France, Russian Federation, Poland
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingRefractory Plasma Cell MyelomaUnited States
-
University of LeedsCompletedRelapsed or Refractory Multiple MyelomaUnited Kingdom
-
Mario BoccadoroActive, not recruiting
-
Regeneron PharmaceuticalsActive, not recruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.Completed
-
Black Sea Hematology AssociationAmgenUnknownMultiple Myeloma | Refractory Multiple Myeloma | Relapse Multiple MyelomaTurkey
-
Memorial Sloan Kettering Cancer CenterExelixisCompletedRelapsed or Refractory Multiple MyelomaUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's Hospital; H. Lee Moffitt...CompletedMultiple Myeloma | Refractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USACompletedMultiple Myeloma | Myeloma | M-Protein | Myeloma Proteins
-
Oxford University Hospitals NHS TrustAmgenCompletedMyeloma | Smouldering Myeloma | Monoclonal Gammopathy of Undetermined Significance (MGUS)United Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRefractory Plasma Cell Myeloma | Plasmacytoma | Recurrent Plasma Cell Myeloma | Plasma Cell LeukemiaUnited States
-
Uppsala UniversityDalarna County Council, Sweden; Uppsala County Council, SwedenNot yet recruitingMyeloma Multiple
-
Robert Flavell, MD, PhDNational Cancer Institute (NCI)RecruitingMultiple Myeloma | Plasma Cell MyelomaUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Recruiting
-
Emory UniversityNational Cancer Institute (NCI); GlaxoSmithKlineRecruitingPlasma Cell MyelomaUnited States
-
Cartesian TherapeuticsRecruiting
-
Memorial Sloan Kettering Cancer CenterRecruitingPlasma Cell MyelomaUnited States
-
Poitiers University HospitalSanofi; Intergroupe Francophone du MyelomeActive, not recruitingMultiple Myeloma | Myeloma | Myeloma MultipleFrance
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH); AmgenActive, not recruitingPlasma Cell MyelomaUnited States
-
SanofiActive, not recruitingPlasma Cell MyelomaFrance, United States, Australia, Brazil, Canada, Czechia, Greece, Hungary, Italy, Japan, Korea, Republic of, New Zealand, Russian Federation, Spain, Turkey, United Kingdom